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1. Introduction 
The first documentation on the myelofibrotic syn- 
drome was published by Heuck in 1879 1 ] who re- 
ported two cases, exhibiting a very high leucocyte 
count and fibrosis of the bone marrow. These, then, 
seemed to be the cases of ‘splenic’ leukemia as it was 
then understood. Neumann [2] interpreted that the mar- 
row might have been hyperplastic before becoming necro- 
tic and might, therefore, have originated the leukemic 
process. However, a different view was taken by 
Donhauser [3]. His patient had splenomegaly; the 
blood showed little anemia and the leucocyte count 
was only 11 550; and the autopsy demonstrated 
myelofibrosis and myeloid metaplasia. In the follow- 
ing years the myelofibrotic syndrome was postulated 
by several investigators [4-81 to have a distinct nature 
of its own and is different from leukemia. Myelofibro- 
tic syndrome typically occurs in middle-aged and 
elderly persons [9-lo] although a few cases have 
been found in children [ 1 l] . 
A variety of etiological factors responsible for 
myelofibrosis have been reported in literature (see 
review by Hunstein and Hauswaldt, [ 121). However, 
no indications of a virus etiology of the disease exist 
as yet. In the present report we will describe the 
existence of a DNA-polymerase in a post-operative 
spleen specimen from a 2% year old girl having myelo- 
fibrotic syndrome; this enzyme resembles in many of 
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its biochemical parameters the DNA-polymerases of 
RNA tumor viruses. The purification of this enzyme 
and some of its biochemical characteristics are de- 
scribed here. 
2. Materials and methods 
Labelled deoxynucleoside triphosphates were 
obtained from NEN-Chemicals GmbH, Germany, 
unlabelled deoxynucleoside triphosphates from 
Calbiochem or Boehringer Mannheim, Tutzing. 
Polycytidylic acid (PC) was supplied by Miles 
Laboratories, Elkhart, Indiana, U.S.A., and oligo 
(dG) by Collaborative Research, Massachusetts. 
Spleen from a patient having osteo-myelofibrosis 
(approx. 1.45 kg) was obtained from a 2% year old 
girl; sectioned and frozen at -70°C. All operations 
were performed at 0-4°C. 100 g of spleen was com- 
bined with 500 ml of buffer containing 0.05 M Tris- 
HCl (pH 7.5), 0.02 M dithiothreitol, 0.0005 M EDTA, 
0.25 M saccharose and 0.005 M MgCla (Buffer B); 
and homogenized under icewater cooling in a Waring 
blendor for 8 min at low speed and 4 min at high speed. 
The suspension was then filtered through a monolayer 
of nylon stocking (Fraction I), and the filtrate centri- 
fuged for 10 min at 900 g in a Sorvall centrifuge using 
an SS-34 rotor. The pellet, containing nuclei, was 
discarded and the supernatant was centrifuged at 
10 000 g for 15 min. The mitochondrial pellet was 
discarded. Following a modified procedure of Mayer 
et al. [ 131, the supernatant was placed on a 25% W/W 
saccharose cushion and centrifuged at 17 1 000 g for 
2 h in a Damon IEC ultracentrifuge using a 404 rotor. 
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The microsomal pellets were solubilized in 100 ml 
buffer containing 0.05 M Tris-HCl (pH 7.5), 0.001 
M dithiothreitol, 0.001 M EDTA, 20% ethylene glycol 
(Buffer A) with 1 .O M NaCl and 0.5% Nonidet P-40, 
and stirred slowly for 1 h (Fraction II). Particulate 
debris was removed by centrifuging at 17 1 000 g for 
1 h. Solubilized microsomal extracts were dialyzed 
against 4 1 of Buffer A for 17 h. 
In a batch method, previously described by Smith 
et al. [ 141 , the extract was adjusted to 0.25 M KC1 
and added to 150 ml of fibrous DEAE-cellulose 
(Serva, capacity 0.69) which had been equilibrated 
with Buffer A + 0.25 M KC1 (1.5 ml gravity-packed 
wet vol per gram starting tissue). All salt concentra- 
tions were determined with a conductivity meter. The 
slurry was gently stirred for 1 h and centrifuged at 
4100 g for 10 min. The supernatant was decanted 
and saved, and the DEAE-cellulose was resuspended 
with 100 ml of Buffer A + 0.30 M KCl, gently stirred 
for 1 h and centrifuged at 4100 g for 10 min. The 
supernatant was decanted, combined with the 
previous supernatant, and dialyzed against 4 1 of 
Buffer A for 18 h (Fraction III). The resultant extract 
was equilibrated to 0.075 M KC1 and applied in batch 
method to 150 ml of granular DEAE-cellulose (Serva- 
ccl, capacity 0.99), equilibrated with Buffer A + 
0.075 M KC1 (1.5 ml gravity-packed wet vol per gram 
starting tissue). The slurry was gently stirred for 1 h, 
then centrifuged at 4100g for 10 min. The super- 
natant was decanted and saved (Fraction IV A). The 
packed DEAE-cellulose was resuspended with 100 ml 
Buffer A, adjusted to 0.3 M KCl, and gently stirred 
for 1 h. The slurry was centrifuged at 4100 g for 10 
min and the supernatant was saved (Fraction IV B). 
Supernatant fractions IV A and IV B were dialyzed 
separately against Buffer A + 30% diethylene glycol 
for 21 h. Fraction IV B was stored at --70°C. 
Using the procedure previously described by Gal10 
et al. [ 151, dialyzed Fraction IV A was adjusted to 
0.05 M KC1 and layered on to a phosphocellulose 
(Serva, type P, capacity 0.85) column (0.9 X 30 cm) 
equilibriated with Buffer A + 0.05 M KC1 (column ~01 
was 0.75 ml gravity-packed wet vol per gram starting 
tissue; ~0175 ml). After the fraction was absorbed, 
a linear gradient from 0.1 M-O.7 5 M KC1 in Buffer 
A + 0.02% Nonidet P-40 and 0.1 mg/ml bovine serum 
albumin in the elution buffers was applied (1250 
ml X 1250 ml). Fractions were collected in 4 ml 
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aliquots and assays were performed on every tenth 
fraction. 
The assay system for Fractions I - V (total vol 0.25 
ml) contained: 0.002 M MgClz or 0.001 M MnClz, 0.08 
M Tris-HCl (pH 7.8), 0.0016 M dithiothreitol (DTT), 
0.4 mM each of unlabelled dATP, dCTP, dGTP (for 
assays containing poly (dA-dT) and poly rA.p(dT),*) 
and dTTP (for assays containing poly rC.oligo dG); 
1 &i [“HI -dTTP (1279 cpm/pmole) or 1 &i [” H] - 
dGTP (192 cpm/pmole), 1 pg of the indicated tem- 
plate, and 0.025 ml of the test fraction. All reactions 
were performed at 37°C for 60 min. Acid precipitable 
material was collected on Whatman glass fiber paper 
discs (GF/C, 2.5 cm @), and counted in a liquid scin- 
tillation spectrometer. Protein was estimated by the 
method of Lowry et al. [ 161. 
3. Results and discussion 
The DNA polymerase activity in the solubilized 
high speed pellet (17 1 000 g) was extracted with salt 
and detergent and purified as described in materials 
and methods. The activities of this enzyme at various 
steps of purification, using different template-primers 
are documented in table 1. The single peak of activity 
eluted from the phosphocellulose column at 0.29 M 
salt concentration (Fraction V), represents a 625-fold 
purification over the enzymatic activity of the crude 
homogenate using poly rC.oligo dG as the template- 
primer. With poly rA.p(dT),, the purification was 
485-fold, and the poly (dA-dT) catalyzed activity 
exhibited a 21 S-fold purification over the homo- 
genate. 
The purification procedure employed here, except 
some minor modifications, is based on the method 
of Mayer, Smith and Gallo [ 13-151. However, in 
our experiments the peak activity was eluted at 0.29 
M KCl, whereas, these authors reported the elution 
of their peak activity at 0.26 M KCl. This minor 
shift of elution peak has been observed by these 
authors in their recent experiments also (Dr R. C. 
Gallo, National Cancer Insitiute, USA; personal com- 
munication). 
It is interesting to note that though the enzyme 
uses all three templates very efficiently throughout 
the purification procedures, the maximum activity 
of the phosphocellulose enzyme is shown in the 
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Table 1 
DNA-polymerase activities at various purification steps” 
Fraction Purification step 
No. 
I Crude homogenate 
~- 
II 17 1 000 g resuspended pellet 
Enzyme activities with various templates 
Incorporation of the labelled precursor (pmoles/mg protein) 
_ 
1’01~ (dA-dT) Poly rA.p(dT),, Poly rC.oligo dG 
____~ 
0.908 0.442 1.571 
(0.4381b 
29.821 12.713 8.520 
(9.620) (5.619) 
III After fibrous DEAL-Cellulose 51.575 13.407 16.935 
-- 
Fraction IV A 21.225 23.430 48.610 
IV After granular DEAE-Cellulose 
Fraction IV B 99.466 25.280 2.403 
V DNA-polymerase activity of fraction 193.933 214.400 983.120 
IV A after phosphocellulose 
--____ 
++ a Assay conditions as described in Materials and methods, using Mg ions and [a II] -dTTP for poly (dA-dT) and poly 
rA.p(dTI,, > and Mn++ ions and [a I-I] -dCTP for poly rC.oligo dG. 
b Figures in brackets are for endogenous incorporation values. 
presence of poly rC.oligo dG. Furthermore, the 
pelleted crude enzyme (Fraction II) shows an endo- 
genous incorporation of [3 H] -TMP and [“HI -dGMP 
(shown in brackets in table 1); the endogenous activity 
was lost in the presence of pancreatic RNase (data not 
shown). 
The use of several synthetic template-primers for 
monitoring viral RNA-dependent DNA polymerase 
(RDDP) has increased because of their relative speci- 
ficity. Among these templates, poly rC.oligo dG and 
poly rA.oligo dT appear to be relatively specific for 
the DNA polymerases associated with oncornaviruses. 
Recently, Lewis et al. [17] have isolated a cellular 
DNA-polymerase III (-/-DNA polymerase) which has 
a very high affinity for the template-primer poly rA. 
oligo dT. The transcription of this template by the 
y-polymerase requires however, Mrr++ ions; whereas, 
in our experiments the transcription of poly rA is 
about 5 times better with M$+ ions than with Mnf’ 
ions (table 2). Gallo et al. [ 151 have reported that 
Table 2 
Template and ionic requirements of the purified DNA-polymerasea 
Template used ’ II-labelled 
precursor 
Incorporation of the labelled 
precursor (pmoles/mg protein) 
WZ+ Mn+’ 
Poly (dA-dT) dTTP 193.93 15.72 
Poly rA.p(dT),, 
Poly rC.oligo dG 
dTTP 214.40 47.69 
dCTP 361.00 983.12 
a Assay conditions as described in Materials and methods. 
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Table 3 
Biochemical properties of the purified enzymea 
October 1975 
Additions Incorporation of the labelled 
precursor (pmoles/mg protein) 
Endogenous system 0.0 
Complete (poly rC.oligo dG) 1054.70 
Minus Md’ 1.63 
Plus RNase (80 ng/ml) 9.54 
“Assay conditions as described in Materials and methods, using poly rC, 
olipo dG as template, and Mn++ for ionic requirements and [ 311] -dGTP as 
labelled precursor. 
oligo dG.poly rC can be used, but weakly, by the y- 
polymerase. In our system, the maximum response 
was observed with poly rC.oligo dG. Again here we 
find an ionic preference, i.e. the enzyme has far better 
activity in the presence of Mn++ ions than with Md+ 
ions. This ionic preference resembles the observations 
made by Howk et al. [ 181, Abrell and Gallo [ 191 
and Dion et al. [20] for DNA polymerase activities 
associated to C-type oncornaviruses. 
The complete dependency of the polymerase 
activity on Mn* ions is shown in table 3; the omission 
of Mn* ions in the complete reaction mixture leads 
to a total inhibition of [3H] -dGMP incorporation 
into DNA. Addition of pancreatic RNase to the 
reaction mixture causes a total loss of enzyme activity, 
indicating the utilization of poly rC strand. This obser- 
vation is important in the sense, that our enzyme is 
unable to incorporate [3 H] -dGMP in the presence of 
oligo dG alone. This type of activity, catalyzed by 
the enzyme terminal transferases, has been shown 
to occur in thymus [2 l-231 , in white blood cells 
of patients with acute lymphoblastic leukemia [24] 
and with chronic myelogenous leukemia [25]. 
The data in table 4 rule out the possibility that 
our enzyme preparation has any terminal transferase 
activity. It is known that terminal transferase works 
best with the primer alone [2 l-251 , and the presence 
of unlabelled deoxynucleoside triphosphates in the 
reaction mixture inhibits the terminal transferase 
activity [2.5]. The data reported in Table 4 give just 
the opposite picture, i.e. the higher activity is obtained 
in the presence of primer hybridized to template poly 
Table 4 
Incorporation of [3H ] -dGMP in the presence of poly rC,oligo 
dG and oligo dG” 
Template 
used 
Additions Incorporation of the 
labelled precursor 
(pmoles/mg protein) 
Poly rC.oligo dG [‘HI-dGTP 
+ (dTTP, dCTP, dATP) 
561.4 
Oligo dG [3H]-dGTP 
+ (dTTP, dCTP, dATP) 
24.5 
Oligo dG 
~__- 
[ 3 H] -dGTP (alone) 0.0 
aAssay conditions as described in Materials and methods. 
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rC, and the [3 H] -dGMP incorporation in the absence 
of other deoxynucleoside triphosphates is zero. 
The data presented here indicate that the DNA- 
polymerase activity purified from a spleen of child- 
hood myelofibrotic syndrome is clearly distinguish- 
able from the y-polymerase (DNA-polymerase III) 
by three criteria: (a) the purification procedure (Gal10 
et al. [ 151); (b) template specificity and (c) ionic 
requirements. The absence of terminal transferase 
activity in the purified enzyme preparation is indicated 
by the RNase digestion experiments, and the inability 
of oligo dG alone to incorporate [3 H] -dGMP. The 
template requirements and the ionic specificity of the 
purified enzyme is identical to the oncornaviral re- 
verse-transcriptase. Further experiments on its physio- 
chemical characterization and its immunological 
relatedness to other primate RNA viruses are in 
progress. 
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